Provided by Tiger Trade Technology Pte. Ltd.

Amneal Pharmaceuticals, Inc.

14.50
-0.1000-0.68%
Post-market: 14.46-0.0378-0.26%17:34 EST
Volume:1.53M
Turnover:22.17M
Market Cap:4.56B
PE:901.12
High:14.67
Open:14.60
Low:14.42
Close:14.60
52wk High:15.42
52wk Low:6.69
Shares:314.36M
Float Shares:168.50M
Volume Ratio:0.79
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0161
EPS(LYR):-0.3783
ROE:-881.26%
ROA:6.79%
PB:-41.64
PE(LYR):-38.33

Loading ...

Feb 03, 2026

Major Issues Report

Form 8-K - Current report
Jan 29, 2026

Major Issues Report

Form 8-K - Current report
Jan 13, 2026

Major Issues Report

Form 8-K - Current report
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2025

Major Issues Report

Form 8-K - Current report
Aug 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]